Kaplan-Meier Curves, Cox Model, and P-Values Are Not Enough for the Prognostic Evaluation of Tumor Markers: Statistical Suggestions for a More Comprehensive …
P Boracchi, P Roccabianca, G Avallone… - Veterinary …, 2021 - journals.sagepub.com
The assessment of prognostic markers is key to the improvement of therapeutic strategies for
cancer patients. Some promising markers may fail to be applied in clinical practice, or some …
cancer patients. Some promising markers may fail to be applied in clinical practice, or some …
Prognostic and predictive markers in canine tumours: rationale and relevance. A review
S Mukaratirwa - Veterinary Quarterly, 2005 - Taylor & Francis
Cancer is one of the most common causes of death in dogs. The availability of multiple
treatment modalities and novel therapeutic targets make the correct diagnosis, prognostic …
treatment modalities and novel therapeutic targets make the correct diagnosis, prognostic …
Handling cause of death in equivocal cases using the EM algorithm
RL Kodell, JJ Chen - Communications in Statistics-Theory and …, 1987 - Taylor & Francis
The statistical analysis of animal bioassays fore carcinogenicity often involves utilizing the
cause of death of each animal. There is considerable disagreement among veterinary …
cause of death of each animal. There is considerable disagreement among veterinary …
Serum biomarker profiling in cancer studies: a question of standardisation?
B Matharoo‐Ball, AK Miles, CS Creaser… - Veterinary and …, 2008 - Wiley Online Library
Companion animals are exposed to similar environmental conditions and carcinogens as
humans. In some animal cancers, there also appears to be the same genetic changes …
humans. In some animal cancers, there also appears to be the same genetic changes …
Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology
There is an increasing need for more accurate prognostic and predictive markers in
veterinary oncology because of an increasing number of treatment options, the increased …
veterinary oncology because of an increasing number of treatment options, the increased …
Clinical techniques in small animal molecular oncology
PJ Bergman - Clinical techniques in small animal practice, 2003 - Elsevier
The diagnosis, staging, and treatment of tumors in veterinary as well as human oncology
have traditionally incorporated elements of anatomic extent of neoplasia through various …
have traditionally incorporated elements of anatomic extent of neoplasia through various …
Markers of prognosis and response to treatment: ready for clinical use in oncology? A biostatistician's viewpoint
P Boracchi, E Biganzoli - The International Journal of …, 2003 - journals.sagepub.com
Cancer is a heterogeneous disease: tumors are highly variable in their growth rates,
patterns of metastases and other biological characteristics. The benefit derived from any …
patterns of metastases and other biological characteristics. The benefit derived from any …
Standardized tumor rates for chronic bioassays
RL Kodell, DW Gaylor, JJ Chen - Biometrics, 1986 - JSTOR
If crude experimental proportions of animals with tumor from chronic bioassays for
carcinogenicity are used for low-dose extrapolation in a risk analysis, different dose-specific …
carcinogenicity are used for low-dose extrapolation in a risk analysis, different dose-specific …
[HTML][HTML] Classification and grading of canine malignant mammary tumors
A Tavasoly, H Golshahi, A Rezaie… - … research forum: an …, 2013 - ncbi.nlm.nih.gov
Histological grading is a good parameter to stratify tumors according to their biological
aggressiveness. The Elston and Ellis grading method in humans, invasive ductal breast …
aggressiveness. The Elston and Ellis grading method in humans, invasive ductal breast …
Biostatistics and tumor marker studies in breast cancer: design, analysis and interpretation issues
E Biganzoli, P Boracchi… - The International Journal …, 2003 - journals.sagepub.com
The development of staging procedures for breast cancer aimed at the identification of
distinct, homogeneous patient categories with different chances of benefiting from treatment …
distinct, homogeneous patient categories with different chances of benefiting from treatment …